Literature DB >> 28673410

Blood-Based Biomarkers for the Identification of Sports-Related Concussion.

Martina Anto-Ocrah1, Courtney Marie Cora Jones2, Danielle Diacovo3, Jeffrey J Bazarian4.   

Abstract

Sports-related concussions (SRCs) are common among athletes in the United States. Most athletes who sustain an SRC recover within 7 to 10 days; however, many athletes who sustain the injury do not recover as expected and experience prolonged, persistent symptoms. In this document, the authors provide an overview of the empirical evidence related to the use of blood-based brain biomarkers in the athlete population for diagnosis of SRCs, prognosis of recovery and return to play guidelines, and indications of neurodegeneration. The authors also provide a summary of research challenges, gaps in the literature, and future directions for research.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Concussion; Sports-related concussion; Traumatic brain injury

Mesh:

Substances:

Year:  2017        PMID: 28673410     DOI: 10.1016/j.ncl.2017.03.008

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  3 in total

Review 1.  Pediatric Sports-Related Concussion: An Approach to Care.

Authors:  Olivia E Podolak; Kristy B Arbogast; Christina L Master; David Sleet; Matthew F Grady
Journal:  Am J Lifestyle Med       Date:  2021-01-21

2.  Risk factors associated with cardiac complication after total joint arthroplasty of the hip and knee: a systematic review.

Authors:  Yassin Elsiwy; Ivana Jovanovic; Kenji Doma; Kaushik Hazratwala; Hayley Letson
Journal:  J Orthop Surg Res       Date:  2019-01-11       Impact factor: 2.359

3.  Salivary S100 calcium-binding protein beta (S100B) and neurofilament light (NfL) after acute exposure to repeated head impacts in collegiate water polo players.

Authors:  Derek C Monroe; Elizabeth A Thomas; Nicholas J Cecchi; Douglas A Granger; James W Hicks; Steven L Small
Journal:  Sci Rep       Date:  2022-03-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.